Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;7(4):e34644.
doi: 10.1371/journal.pone.0034644. Epub 2012 Apr 10.

Evaluation of microbubbles as contrast agents for ultrasonography and magnetic resonance imaging

Ling Li  1 , Qiang Wei, Hong-Bo Li, Song Wen, Gao-Jun Teng
Affiliations

Evaluation of microbubbles as contrast agents for ultrasonography and magnetic resonance imaging

Ling Li et al. PLoS One. 2012.

Abstract

Background: Microbubbles (MBs) can serve as an ultrasound contrast agent, and has the potential for magnetic resonance imaging (MRI). Due to the relatively low effect of MBs on MRI, it is necessary to develop new MBs that are more suitable for MRI. In this study, we evaluate the properties of SonoVue® and custom-made Fe(3)O(4)-nanoparticle-embedded microbubbles (Fe(3)O(4)-MBs) in terms of contrast agents for ultrsonography (US) and MRI.

Methodology/principal findings: A total of 20 HepG2 subcutaneous-tumor-bearing nude mice were randomly assigned to 2 groups (i.e., n = 10 mice each group), one for US test and the other for MRI test. Within each group, two tests were performed for each mouse. The contrast agent for the first test is SonoVue®, and the second is Fe(3)O(4)-MBs. US was performed using a Technos(MPX) US system (Esaote, Italy) with a contrast-tuned imaging (CnTI™) mode. MRI was performed using a 7.0T Micro-MRI (PharmaScan, Bruker Biospin GmbH, Germany) with an EPI-T(2)* sequence. The data of signal-to-noise ratio (SNR) from the region-of-interest of each US and MR image was calculated by ImageJ (National Institute of Health, USA). In group 1, enhancement of SonoVue® was significantly higher than Fe(3)O(4)-MBs on US (P<0.001). In group 2, negative enhancement of Fe(3)O(4)-MBs was significantly higher than SonoVue® on MRI (P<0.001). The time to peak showed no significant differences between US and MRI, both of which used the same MBs (P>0.05). The SNR analysis of the enhancement process reveals a strong negative correlation in both cases (i.e., SonoVue® r = -0.733, Fe(3)O(4)-MBs r = -0.903, with P<0.05).

Conclusions: It might be important to change the Fe(3)O(4)-MBs' shell structure and/or the imagining strategy of US to improve the imaging quality of Fe(3)O(4)-MBs on US. As an intriguing prospect that can be detected by US and MRI, MBs are worthy of further study.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. In vitro US experiments.
Images of SonoVue® and Fe3O4-MBs under the mode of CnTI™ and Flash: (A) In the first half of the tube, in CnTI® mode, SonoVue® showed high echo; in the second half, in Flash mode, the SonoVue® microbubbles broke and the enhanced signal generated by the microbubbles changed to anecho (white arrow). (B) Under the same imaging strategy change, the signal of Fe3O4-MBs tube had little change (white arrow).
Figure 2
Figure 2. In vitro MRI experiments.
The in vitro MR images of different volume fraction of SonoVue® and Fe3O4-MBs: (A). 1: sodium chloride solution (0.9% w/v), 2–4: SonoVue® with different volume fraction (1.75%, 3.5%, 7.0%). 5–7: Fe3O4-MBs with different volume fraction (1.75%, 3.5%, 7.0%). (B) an approximately linear relationship was observed in SonoVue® (r = −0.982, P<0.05) between SNR and microbubble volume fraction. (C) an approximately linear relationship was observed in Fe3O4-MBs (r = −0.929, P<0.05) between SNR and microbubble volume fraction.
Figure 3
Figure 3. Representative US findings with SonoVue® and Fe3O4-MBs.
Images from the same mouse: (A) gray-scale image of the tumor with a size 0.79 mm×0.34 mm, (B) under CnTI™ mode just before microbubble injection, signals from tumor was suppressed (white arrow), (C) maximum contrast enhancement US tumor image after SonoVue® injection (white arrow), and (D) maximum contrast enhancement US tumor image after Fe3O4-MBs injection (white arrow).
Figure 4
Figure 4. SNR time courses of the same mouse tumor in US by using SonoVue® and Fe3O4-MBs.
Figure A shows the SNR time course in ROI during SonoVue® injection and Figure B shows the SNR time course when using Fe3O4-MBs injection.
Figure 5
Figure 5. Representative MRI findings with SonoVue® and Fe3O4-MBs.
Images from the same mouse during microbubble injection: (A) anatomical image showing the superficial tumor (white arrow), (B) pre-injection EPI-T2* MRI tumor image (white arrow), (C) maximum contrast enhancement of the tumor after SonoVue® injection (white arrow), and (D) maximum contrast enhancement of the tumor after Fe3O4-MBs injection (white arrow).
Figure 6
Figure 6. SNR time courses of MRI from SonoVue® and Fe3O4-MBs.
Figure A shows the SNR time course in ROI during SonoVue® injection and Figure B shows the SNR time course when using Fe3O4-MBs.
Figure 7
Figure 7. Correlation between the US and MRI.
Figure A shows the signal strength correlation between US and MRI in 600 seconds of enhancement when using SonoVue® (r = −0.733, P<0.05). Figure B shows the signal strength correlation between US and MRI in 600 seconds of enhancement when using Fe3O4-MBs (r = −0.903, P<0.05).
See this image and copyright information in PMC

References

    1. Folkman J. Angiogenesis. Annu Rev Med. 2006;57:1–18. - PubMed
    1. Cosgrove D. Ultrasound contrast agents: An overview. Eur J Radiol. 2006;60:324–330. - PubMed
    1. Voigt JU. Ultrasound molecular imaging. Methods. 2009;48:92–97. - PubMed
    1. Wong KK, Huang I, Kim YR, Tang H, Yang ES, et al. In vivo study of microbubbles as an MR susceptibility contrast agent. Magn Reson Med. 2004;52:445–452. - PubMed
    1. Alexander AL, McCreery TT, Barrette TR, Gmitro AF, Unger EC. Microbubbles as novel pressure-sensitive MR contrast agents. Magn Reson Med. 1996;35:801–806. - PubMed

Publication types